Phase II study of 4'-epi-doxorubicin in advanced breast cancer.
D000328:Adult; D000368:Aged; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D004317:Doxorubicin / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D015251:Epirubicin; D005260:Female; D006801:Humans; D008875:Middle Aged
D000903:Antibiotics, Antineoplastic; D015251:Epirubicin; D004317:Doxorubicin